Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Dramatic impact of rapid point of care nucleic acid testing for SARS-CoV-2 in hospitalised patients: a clinical validation trial and implementation study

Dami Collier, Sonny M. Assennato, Ben Warne, Nyarie Sithole, Katherine Sharrocks, Allyson Ritchie, Pooja Ravji, Matthew Routledge, Dominic Sparkes, Jordan Skittrall, Anna Smielewska, Isobel Ramsey, Neha Goel, Martin Curran, David Enoch, Rhys Tassell, Michelle Lineham, Devan Vaghela, Clare Leong, Hoi Ping Mok, John Bradley, Kenneth GC Smith, Vivienne Mendoza, Nikos Demiris, Martin Besser, Gordon Dougan, Paul J. Lehner, Mark J. Siedner, Hongyi Zhang, Claire S. Waddington, Helen Lee, View ORCID ProfileRavindra K. Gupta, and the CITIID-NIHR COVID BioResource Collaboration
doi: https://doi.org/10.1101/2020.05.31.20114520
Dami Collier
1Division of Infection and Immunity, University College London, UK. WC1E 6BT
2Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK. CB2 0AW
Roles: specialist registrar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sonny M. Assennato
3Diagnostics for the Real World EU Ltd., Chesterford Research Park, UK. CB10 1XL
Roles: post-doctoral researcher
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ben Warne
2Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK. CB2 0AW
4Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK. CB2 0QQ
7Department of Medicine, University of Cambridge, Cambridge, UK. CB2 0AW
Roles: specialist registrar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nyarie Sithole
4Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK. CB2 0QQ
Roles: specialist registrar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katherine Sharrocks
4Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK. CB2 0QQ
Roles: specialist registrar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Allyson Ritchie
3Diagnostics for the Real World EU Ltd., Chesterford Research Park, UK. CB10 1XL
Roles: post-doctoral researcher
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pooja Ravji
4Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK. CB2 0QQ
Roles: specialist registrar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew Routledge
4Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK. CB2 0QQ
Roles: specialist registrar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dominic Sparkes
4Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK. CB2 0QQ
Roles: specialist registrar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jordan Skittrall
4Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK. CB2 0QQ
Roles: specialist registrar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Smielewska
4Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK. CB2 0QQ
Roles: specialist registrar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isobel Ramsey
4Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK. CB2 0QQ
Roles: specialist registrar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neha Goel
3Diagnostics for the Real World EU Ltd., Chesterford Research Park, UK. CB10 1XL
Roles: doctoral student
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Curran
5Clinical Microbiology & Public Health Laboratory, Public Health England, Cambridge, UK. CB2 0QQ
Roles: Clinical Scientist
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Enoch
5Clinical Microbiology & Public Health Laboratory, Public Health England, Cambridge, UK. CB2 0QQ
Roles: consultant microbiologist
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rhys Tassell
6POC Testing, Department of Pathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. CB2 0QQ
Roles: POC testing lead
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michelle Lineham
6POC Testing, Department of Pathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. CB2 0QQ
Roles: POC team member
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Devan Vaghela
4Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK. CB2 0QQ
Roles: specialist registrar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clare Leong
4Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK. CB2 0QQ
Roles: specialist registrar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hoi Ping Mok
4Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK. CB2 0QQ
Roles: consultant physician
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Bradley
7Department of Medicine, University of Cambridge, Cambridge, UK. CB2 0AW
8National Institutes for Health Research Cambridge Biomedical Research Centre, Cambridge, UK. CB2 0QQ
Roles: professor of medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth GC Smith
2Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK. CB2 0AW
7Department of Medicine, University of Cambridge, Cambridge, UK. CB2 0AW
Roles: professor of medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vivienne Mendoza
9NIHR Cambridge Clinical Research Facility, Cambridge, UK. CB2 0QQ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nikos Demiris
10Department of Statistics, Athens University of Economics and Business, 28is Oktovriou 76, 104 34, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Besser
11Department of Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. CB2 0QQ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gordon Dougan
2Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK. CB2 0AW
7Department of Medicine, University of Cambridge, Cambridge, UK. CB2 0AW
Roles: professor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul J. Lehner
2Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK. CB2 0AW
7Department of Medicine, University of Cambridge, Cambridge, UK. CB2 0AW
Roles: professor of immunology and medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark J. Siedner
12Africa Health Research Institute, Durban, 4001. South Africa
13University of KwaZulu-Natal, Durban, South Africa
14Massachusetts General Hospital, Boston, MA, USA
15Harvard Medical School, Boston, MA, USA
Roles: associate professor of medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hongyi Zhang
5Clinical Microbiology & Public Health Laboratory, Public Health England, Cambridge, UK. CB2 0QQ
Roles: consultant microbiologist
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claire S. Waddington
4Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK. CB2 0QQ
7Department of Medicine, University of Cambridge, Cambridge, UK. CB2 0AW
Roles: clinical lecturer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Helen Lee
3Diagnostics for the Real World EU Ltd., Chesterford Research Park, UK. CB10 1XL
Roles: CEO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ravindra K. Gupta
2Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK. CB2 0AW
4Department of Infectious Diseases, Cambridge University NHS Hospitals Foundation Trust, Cambridge, UK. CB2 0QQ
7Department of Medicine, University of Cambridge, Cambridge, UK. CB2 0AW
12Africa Health Research Institute, Durban, 4001. South Africa
13University of KwaZulu-Natal, Durban, South Africa
Roles: professor of clinical microbiology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ravindra K. Gupta
  • For correspondence: rkg20@cam.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background There is urgent need for safe and efficient triage protocols for hospitalized COVID-19 suspects to appropriate isolation wards. A major barrier to timely discharge of patients from the emergency room and hospital is the turnaround time for many SARS-CoV-2 nucleic acid tests. We validated a point of care nucleic acid amplification based platform SAMBA II for diagnosis of COVID-19 and performed an implementation study to assess its impact on patient disposition at a major academic hospital.

Methods We prospectively recruited COVID-19 suspects admitted to hospital (NCT04326387). In an initial pilot phase, individuals were tested using a nasal/throat swab with the SAMBA II SARS-CoV-2 rapid diagnostic platform in parallel with a combined nasal/throat swab for standard central laboratory RT-PCR testing. In the second implementation phase, we examined the utility of adding the SAMBA platform to routine care. In the pilot phase, we measured concordance and assay validity using the central laboratory as the reference standard and assessed assay turnaround time. In the implementation phase, we assessed 1) time to definitive bed placement from admission, 2) time spent on COVID-19 holding wards, 3) proportion of patients in isolation versus COVID negative areas following a test, comparing the implementation phase with the 10 days prior to implementation.

Results In phase I, 149 participants were included in the pilot. By central laboratory RT-PCR testing, 32 (21.5%) tested positive and 117 (78.5%). Sensitivity and specificity of the SAMBA assay compared to RT-PCR lab test were 96.9% (95% CI 0.838-0.999) and 99.1% (0.953-0.999), respectively. Median time to result was 2.6 hours (IQR 2.3 to 4.8) for SAMBA II SARS-CoV-2 test and 26.4 hours (IQR 21.4 to 31.4) for the standard lab RT-PCR test (p<0.001). In the first 10 days of the SAMBA implementation phase, we conducted 992 tests, with the majority (59.8%) used for hospital admission, and the remainder for pre-operative screening (11.3%), discharge planning (10%), in-hospital screening of new symptoms (9.7%). Comparing the pre-implementation (n=599) with the implementation phase, median time to definitive bed placement from admission was reduced from 23.4 hours (8.6-41.9) to 17.1 hours (9.0-28.8), P=0.02 in Cox analysis, adjusted for age, sex, comorbidities and clinical severity at presentation. Mean length of stay on a COVID-19 ‘holding’ ward decreased from 58.5 hours to 29.9 hours (P<0.001). Use of single occupancy rooms amongst those tested fell from 30.8% before to 21.2% (P=0.03) and 11 hospital bay closures (on average 6 beds each) were avoided after implementation of the POC assay.

Conclusions The SAMBA II SARS-CoV-2 rapid assay performed well compared to a centralized laboratory RT-PCR platform and demonstrated shorter time to result both in trial and real-world settings. It was also associated with faster time to definitive bed placement from the emergency room, greater availability of isolation rooms, avoidance of hospital bay closures, and greater movement of patients to COVID negative open “green” category wards. Rapid testing in hospitals has the potential to transform ability to deal with the COVID-19 epidemic.

Competing Interest Statement

This work was supported by the Wellcome Trust (Senior Research Fellowship to RKG WT108082AIA and PhD Research Fellowship to DAC; Principal Research Fellowship 210688/Z/18/Z to PJL), Addenbrookes Charitable Trust to PJL, National Institute of Health Research (NIHR) Cambridge BRC

Clinical Trial

NCT04326387

Funding Statement

This work was supported by the Wellcome Trust (Senior Research Fellowship to RKG WT108082AIA and PhD Research Fellowship to DAC; Principal Research Fellowship 210688/Z/18/Z to PJL), Addenbrookes Charitable Trust to PJL, National Institute of Health Research (NIHR) Cambridge Biomedical Research Centre.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The protocol was approved by the East of England - Essex Research Ethics Committee. HRA and Health and Care Research Wales (HCRW) approval was received.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

data can be obtained from the corresponding author by email at rkg20{at}cam.ac.uk

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted June 11, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Dramatic impact of rapid point of care nucleic acid testing for SARS-CoV-2 in hospitalised patients: a clinical validation trial and implementation study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Dramatic impact of rapid point of care nucleic acid testing for SARS-CoV-2 in hospitalised patients: a clinical validation trial and implementation study
Dami Collier, Sonny M. Assennato, Ben Warne, Nyarie Sithole, Katherine Sharrocks, Allyson Ritchie, Pooja Ravji, Matthew Routledge, Dominic Sparkes, Jordan Skittrall, Anna Smielewska, Isobel Ramsey, Neha Goel, Martin Curran, David Enoch, Rhys Tassell, Michelle Lineham, Devan Vaghela, Clare Leong, Hoi Ping Mok, John Bradley, Kenneth GC Smith, Vivienne Mendoza, Nikos Demiris, Martin Besser, Gordon Dougan, Paul J. Lehner, Mark J. Siedner, Hongyi Zhang, Claire S. Waddington, Helen Lee, Ravindra K. Gupta, and the CITIID-NIHR COVID BioResource Collaboration
medRxiv 2020.05.31.20114520; doi: https://doi.org/10.1101/2020.05.31.20114520
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Dramatic impact of rapid point of care nucleic acid testing for SARS-CoV-2 in hospitalised patients: a clinical validation trial and implementation study
Dami Collier, Sonny M. Assennato, Ben Warne, Nyarie Sithole, Katherine Sharrocks, Allyson Ritchie, Pooja Ravji, Matthew Routledge, Dominic Sparkes, Jordan Skittrall, Anna Smielewska, Isobel Ramsey, Neha Goel, Martin Curran, David Enoch, Rhys Tassell, Michelle Lineham, Devan Vaghela, Clare Leong, Hoi Ping Mok, John Bradley, Kenneth GC Smith, Vivienne Mendoza, Nikos Demiris, Martin Besser, Gordon Dougan, Paul J. Lehner, Mark J. Siedner, Hongyi Zhang, Claire S. Waddington, Helen Lee, Ravindra K. Gupta, and the CITIID-NIHR COVID BioResource Collaboration
medRxiv 2020.05.31.20114520; doi: https://doi.org/10.1101/2020.05.31.20114520

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (172)
  • Anesthesia (51)
  • Cardiovascular Medicine (456)
  • Dentistry and Oral Medicine (83)
  • Dermatology (55)
  • Emergency Medicine (160)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (192)
  • Epidemiology (5317)
  • Forensic Medicine (3)
  • Gastroenterology (199)
  • Genetic and Genomic Medicine (767)
  • Geriatric Medicine (81)
  • Health Economics (216)
  • Health Informatics (704)
  • Health Policy (364)
  • Health Systems and Quality Improvement (224)
  • Hematology (100)
  • HIV/AIDS (166)
  • Infectious Diseases (except HIV/AIDS) (5971)
  • Intensive Care and Critical Care Medicine (368)
  • Medical Education (107)
  • Medical Ethics (25)
  • Nephrology (83)
  • Neurology (781)
  • Nursing (43)
  • Nutrition (135)
  • Obstetrics and Gynecology (147)
  • Occupational and Environmental Health (237)
  • Oncology (483)
  • Ophthalmology (155)
  • Orthopedics (40)
  • Otolaryngology (98)
  • Pain Medicine (39)
  • Palliative Medicine (20)
  • Pathology (141)
  • Pediatrics (224)
  • Pharmacology and Therapeutics (138)
  • Primary Care Research (99)
  • Psychiatry and Clinical Psychology (868)
  • Public and Global Health (2051)
  • Radiology and Imaging (356)
  • Rehabilitation Medicine and Physical Therapy (160)
  • Respiratory Medicine (288)
  • Rheumatology (96)
  • Sexual and Reproductive Health (75)
  • Sports Medicine (77)
  • Surgery (110)
  • Toxicology (25)
  • Transplantation (30)
  • Urology (40)